Products
16395 Results
Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 90.1 | 3.89 | ― | ― | 1 | -15.43% | -16.52% | -57.16% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 90.1 | 1.64 | ― | ― | 1 | -20.39% | -21.90% | -81.30% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 90.1 | 10.9 | 0.270 | 11.17 | 1 | 20.84% | ― | 20.84% | 12 May. 2025 | |
Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 90.1 | 1.7 | ― | ― | 1 | 18.06% | 16.44% | -84.53% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 90.1 | 3.8 | ― | ― | 1 | 11.76% | 11.11% | -64.35% | 13 Oct. 2023 | |
Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 90.1 | 10.78 | 0.090 | 10.87 | 1 | 19.38% | ― | 19.38% | 12 May. 2025 | |
Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 90.1 | 0.61 | ― | ― | 1 | 24.49% | 22.00% | -94.61% | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1396328325 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -99.99% | 12 Feb. 2025 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.14 | 0.020 | 0.16 | 1 | -17.65% | -17.65% | -98.98% | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1346000271 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.058 | 0.003 | 0.061 | 1 | -13.43% | -7.94% | -99.52% | 9 Jul. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1396327897 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.086 | 0.003 | 0.089 | 1 | -28.33% | -4.44% | -99.28% | 29 Jan. 2025 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -99.99% | 23 Feb. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -99.99% | 11 Mar. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.56 | 0.030 | 0.59 | 1 | -17.65% | -11.11% | -95.39% | 29 Jan. 2025 | |
Novo Nordisk Constant Leverage with ISIN code: CH1396327905 | Novo Nordisk | Constant Leverage | Long | ― | 436.96 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -99.99% | 29 Jan. 2025 | |
Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 436.96 | 9.24 | 0.110 | 9.35 | 1 | 11.19% | -2.63% | -22.35% | 13 Oct. 2023 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 436.96 | 1.81 | 0.030 | 1.84 | 1 | 17.53% | -6.22% | -86.31% | 23 Feb. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1290993000 | Novo Nordisk | Constant Leverage | Short | ― | 436.96 | 0.007 | 0.002 | 0.009 | 1 | 16.67% | -12.50% | -99.95% | 23 Feb. 2024 | |
Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 436.96 | 11.83 | 0.270 | 12.1 | 1 | 24.26% | ― | 3.05% | 7 May. 2025 | |
Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 129.849 | 0.88 | 0.010 | 0.89 | 1 | 31.34% | 100.00% | -88.60% | 3 Feb. 2023 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.